Skip to main content
Log in

Genetic variants in the ADD1 and GNB3 genes and blood pressure response to potassium supplementation

  • Research Article
  • Published:
Frontiers of Medicine in China Aims and scope Submit manuscript

Abstract

Dietary potassium-supplementation has been associated with a decreased risk of hypertension and other cardiovascular outcomes. However, blood pressure (BP) responses to potassium supplementation vary among individuals. This study was designed to examine the association between 12 single nucleotide polymorphisms (SNPs) in the adducin 1 alpha (ADD1) and guanine nucleotide binding protein (G protein) beta polypeptide 3 (GNB3) genes and systolic BP (SBP), diastolic BP (DBP), and mean arterial pressure (MAP) responses to potassium-supplementation. We conducted a 7-day high-sodium intervention (307.8 mmol sodium/day) followed by a 7-day high-sodium with potassium-supplementation (60 mmol potassium/day) among 1906 Han Chinese participants from rural north China. BP measurements were obtained at the end of each intervention period using a random-zero sphygmomanometer. We identified significant associations between ADD1 variant rs17833172 and SBP, DBP, and MAP responses to potassium-supplementation (all P < 0.0001) that remained significant after adjustment for multiple comparisons. In participants that were heterozygous or homozygous for the G allele of this marker, SBP, DBP, and MAP response to potassium-supplementation were − 3.52 ( − 3.82, − 3.21), − 1.41 ( − 1.66, − 1.15) and − 2.12 ( − 2.37, − 1.87), respectively, as compared to the corresponding responses of 1.99 (0.25, 3.73), − 0.65 ( − 0.10, − 0.21), and − 0.23 ( − 0.37, 0.83), respectively, for those who were homozygous for A allele. In addition, participants with at least one copy of the G allele of rs12503220 of the ADD1 gene had significantly increased DBP and MAP response to potassium-supplementation (P = 0.0041 and 0.01, respectively), which was also significant after correction for multiple testing. DBP and MAP responses to potassium-supplementation were − 1.36 ( − 1.63, − 1.10) and − 2.07 ( − 2.32, − 1.82) for those with at least G allele compared to corresponding responses of 0.86 ( − 0.68, 2.40) and − 0.45 ( − 1.74, 0.84) for those who were homozygous for A allele. In summary, our study identified novel associations between genetic variants of the ADD1 gene and BP response to potassium-supplementation, which could have important clinical and public health implications. Future studies aimed at replicating these novel findings are warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adrogue H J, Madias N E. Sodium and potassium in the pathogenesis of hypertension. N Engl J Med, 2007, 356(19): 1966–1978

    Article  CAS  PubMed  Google Scholar 

  2. Iwamoto T, Kita S. Hypertension, Na+/Ca2+ exchanger, and Na+, K+-ATPase. Kidney Int, 2006, 69(12): 2148–2154

    Article  CAS  PubMed  Google Scholar 

  3. O’shaughnessy K M, Karet F E. Salt handling and hypertension. J Clin Invest, 2004, 113(8): 1075–1081

    PubMed  Google Scholar 

  4. He F J, MacGregor G A. Fortnightly review: Beneficial effects of potassium. BMJ, 2001, 323(7311): 497–501

    Article  CAS  PubMed  Google Scholar 

  5. He J, Gu D, Chen J, Jaquish C E, Rao D C, Hixson J E, Chen J C, Duan X, Huang J F, Chen C S, Kelly T N, Bazzano L A, Whelton P K; GenSalt Collaborative Research Group. Gender difference in blood pressure responses to dietary sodium intervention in the GenSalt study. J Hypertens, 2009, 27(1): 48–54

    Article  CAS  PubMed  Google Scholar 

  6. Whelton P K, He J, Cutler J A, Brancati F L, Appel L J, Follmann D, Klag M J. Effects of oral potassium on blood pressure. Metaanalysis of randomized controlled clinical trials. JAMA, 1997, 277(20): 1624–1632

    Article  CAS  PubMed  Google Scholar 

  7. Gu D, He J, Wu X, Duan X, Whelton P K. Effect of potassium supplementation on blood pressure in Chinese: a randomized, placebo-controlled trial. J Hypertens, 2001, 19(7): 1325–1331

    Article  CAS  PubMed  Google Scholar 

  8. Marteau J B, Zaiou M, Siest G, Visvikis-Siest S. Genetic determinants of blood pressure regulation. J Hypertens, 2005, 23(12): 2127–2143

    Article  CAS  PubMed  Google Scholar 

  9. Beeks E, Kessels A G, Kroon A A, van der Klauw M M, de Leeuw P W. Genetic predisposition to salt-sensitivity: a systematic review. J Hypertens, 2004, 22(7): 1243–1249

    Article  CAS  PubMed  Google Scholar 

  10. Bianchi G, Ferrari P, Staessen J A. Adducin polymorphism: detection and impact on hypertension and related disorders. Hypertension, 2005, 45(3): 331–340

    Article  CAS  PubMed  Google Scholar 

  11. Manunta P, Citterio L, Lanzani C, Ferrandi M. Adducin polymorphisms and the treatment of hypertension. Pharmacogenomics, 2007, 8(5): 465–472

    Article  CAS  PubMed  Google Scholar 

  12. Beeks E, Janssen R G, Kroon A A, Keulen E T, Geurts J M, de Leeuw P W, de Bruin T W. Association between the alpha-adducin Gly460Trp polymorphism and systolic blood pressure in familial combined hyperlipidemia. Am J Hypertens, 2001, 14(12): 1185–1190

    Article  CAS  PubMed  Google Scholar 

  13. Bagos P G, Elefsinioti A L, Nikolopoulos G K, Hamodrakas S J. The GNB3 C825T polymorphism and essential hypertension: a meta-analysis of 34 studies including 14,094 cases and 17,760 controls. J Hypertens, 2007, 25(3): 487–500

    Article  CAS  PubMed  Google Scholar 

  14. GenSalt: rationale, design, methods and baseline characteristics of study participants. J Hum Hypertens, 2007, 21(8): 639–646

    Google Scholar 

  15. Perloff D, Grim C, Flack J, Frohlich E D, Hill M, McDonald M, Morgenstern B Z. Human blood pressure determination by sphygmomanometry. Circulation, 1993, 88(5 Pt 1): 2460–2470

    CAS  PubMed  Google Scholar 

  16. International HapMap Consortium. The International HapMap Project. Nature, 2003, 426(6968): 789–796

    Article  Google Scholar 

  17. Hinds D, Risch M. The ASPEX package: affected sib-pair exclusion mapping v1.88, 1999

  18. Abecasis G R, Cherny S S, Cookson W O, Cardon L R. GRR: graphical representation of relationship errors. Bioinformatics, 2001, 17(8): 742–743

    Article  CAS  PubMed  Google Scholar 

  19. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira M A, Bender D, Maller J, Sklar P, de Bakker P I, Daly M J, Sham P C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet, 2007, 81(3): 559–575

    Article  CAS  PubMed  Google Scholar 

  20. O’Connell J R, Weeks D E. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet, 1998, 63(1): 259–266

    Article  PubMed  Google Scholar 

  21. Abecasis G R, Cherny S S, Cookson W O, Cardon L R. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. [see comment]. Nat Genet, 2002, 30(1): 97–101

    Article  CAS  PubMed  Google Scholar 

  22. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc, Series B (Methodological), 1995, 57(1): 289–300

    Google Scholar 

  23. Gerhard T, Gong Y, Beitelshees A L, Mao X, Lobmeyer M T, Cooper-DeHoff R M, Langaee T Y, Schork N J, Shriver M D, Pepine C J, Johnson J A; INVEST Investigators. Alpha-adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES). Am Heart J, 2008, 156(2): 397–404

    Article  CAS  PubMed  Google Scholar 

  24. Manunta P, Cusi D, Barlassina C, Righetti M, Lanzani C, D’Amico M, Buzzi L, Citterio L, Stella P, Rivera R, Bianchi G. Alphaadducin polymorphisms and renal sodium handling in essential hypertensive patients. Kidney Int, 1998, 53(6): 1471–1478

    Article  CAS  PubMed  Google Scholar 

  25. Schorr U, Blaschke K, Beige J, Distler A, Sharma A M. G-protein beta3 subunit 825T allele and response to dietary salt in normotensive men. J Hypertens, 2000, 18(7): 855–859

    Article  CAS  PubMed  Google Scholar 

  26. Daimon M, Sato H, Sasaki S, Toriyama S, Emi M, Muramatsu M, Hunt S C, Hopkins P N, Karasawa S, Wada K, Jimbu Y, Kameda W, Susa S, Oizumi T, Fukao A, Kubota I, Kawata S, Kato T. Salt consumption-dependent association of the GNB3 gene polymorphism with type 2 DM. Biochem Biophys Res Commun, 2008, 374(3): 576–580

    Article  CAS  PubMed  Google Scholar 

  27. Schelleman H, Klungel O H, Witteman J C, Breteler M M, Hofman A, van Duijn C M, de Boer A, Stricker B H. Diuretic-gene interaction and the risk of myocardial infarction and stroke. Pharmacogenomics J, 2007, 7(5): 346–352

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Dong-Feng Gu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, DH., Liu, DP., Wang, LY. et al. Genetic variants in the ADD1 and GNB3 genes and blood pressure response to potassium supplementation. Front. Med. China 4, 59–66 (2010). https://doi.org/10.1007/s11684-010-0015-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-010-0015-8

Keywords

Navigation